Notice of Extraordinary General Meeting
October 13, 2023
Notice is hereby given that an Extraordinary General Meeting (EGM) of Imagion Biosystems Limited (Imagion or Company) will be held at the offices of K&L
Press & Media Coverage
Catch up on our latest press coverage
Imagion Presents Ovarian Cancer Data at AACR Conference
October 9, 2023
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to provide highlights from
October 2023 Newsletter
October 5, 2023
Our October Newsletter Highlights: 🔹 Scientific poster accepted at AACR Ovarian Cancer Conference 🔹 Strategic partnership signed with Prestige Biopharma for pancreatic cancer 🔹 Imagion
Investor Update: Operating Expenses and MagSense HER2 Program
October 2, 2023
Highlights: Reduces operating expenses Update on MagSense® HER2 program MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
September 19, 2023
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it
1H2023 Half-Year Results
August 30, 2023
1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan
Watch our latest media coverage
Recent Press Coverage
14:13
4:13
4:09
4:19
16:09
5:26
7:30
16:30
18:44
3:10
4:41
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.